Institutional investors purchased a net $3.2 million shares of IMMU during the quarter ended June 2016, and now own 54.94% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
VENBIO SELECT ADVISOR LLC Bought 7.5 Million shares of Immunomedics Inc
TOURBILLON CAPITAL PARTNERS LP Bought 2.4 Million shares of Immunomedics Inc
RENAISSANCE TECHNOLOGIES LLC Bought 1.8 Million shares of Immunomedics Inc